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ABSTRACT 
The loss of cartilage tissue due to trauma, tumor surgery or congenital defects like 
microtia and anotia is one of the major concerns in head and neck surgery. Recently 
tissue engineering approaches including gene delivery have been proposed for 
regeneration of cartilage tissue. In this study, primary chondrocytes were genetically 
modified with plasmid encoding Bone Morphogenetic Protein-7 (BMP-7) via 
commercially available non-viral Turbofect vector with the aim of bringing  ex-vivo 
transfected chondrocytes to re-synthesize BMP-7 n-vitro as they would in-vivo. 
Genetically modified cells were implanted into gelatin/oxide dextran scaffolds and 
cartilage tissue formation was investigated in 15x15mm auricular cartilage defects in-
vivo in 48 New Zealand (NZ) White Rabbits for 4 months. Results were evaluated via 
histology and early gene expression. Early gene expression results indicated  a strong 
effect of exogenous BMP7 on matrix synthesis and chondrocyte growth. In addition, 
histological analysis  results exhibited significantly better cartilage healing with BMP-7 
modified (transfected) cells in comparison to the non-modified (non-transfected) group 
and as well as the control. 
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1. Introduction 
In head and neck surgery, cartilage tissue reconstruction still needs state-of-the art 
approaches to replace the loss of cartilage tissue after trauma, tumor resection, and 
congenital defects like microtia and anotia. Using autologous costal cartilage is the 
traditional method of surgery, however, there may not be enough cartilage tissue 
available and the type of cartilage may not be suitable for this kind of application. In 
addition, costal cartilage is difficult to form to a proper shape which may lead to 
symmetrical and aesthetic problems (Quatela et al., 1995; Pan et al., 2007).  Some other 
complications such as autologous scarcity, pain, donor site-directed morbidity, iatrogenic 
pneumothorax atelectasis and graft incompatibility are also noted (Koch et al., 2002).  
Polymeric biomaterials such as  silicone or porous polyethylene (PE) prostheses are also 
a widely used for re-shaping and the support of the defect area (Romo et al., 2006; 
Breugem et al., 2011). However, there are still some important limitations also to these 
approaches including requirements for intensive care, infection risk, wear and tear in time 
and frequent replacement. There is still the possibility that these materials are seen as 
foreign materials by the body (Koch et al. 2002 , Bauer et al., 2009). Also all these 
surgical operations are technically very demanding and multi-step procedures that require 
well-trained surgeons. In the hand of inexperienced surgeons, results may be poor. 
Several promising tissue engineering approaches for cartilage defect healing and 
regeneration have been proposed (Osch et al 2004; Chung et al 2006).   Rotter et al. have 
summarized the initial tissue engineering efforts of in-vivo and in-vitro cartilage 
development for microtia treatment (Rotter et al., 2008). Yamaoka and his colleagues 
compared various types of hydrogel matrices for auricular cartilage tissue development 
(Yamaoka et al., 2006). Yoo and co-workers have evaluated cell behavior and cartilage 
formation on hyaluronic acid modified macroporous poly(D,L-lactic acid-co-glycolic 
acid) scaffolds (Yoo et al., 2005). 
Recent approaches also include, using growth factors or stimulants for engineered 
therapy. Bone Morphogenetic Proteins (BMP’s) are considered as good candidates for 
these treatments. (Reddi et al., 1998; Boyne et al., 2001). BMPs are growth factors that 
act as enhancers for extracellular matrix synthesis and are inducers of mitotic activity 
(Bessa et al., 2008). There have been several studies reported about using BMPs or other 
cytokines for articular cartilage repair. Gelse and co-workers demonstrated articular 
cartilage repair by gene therapy, using BMP-2 and growth factor producing mesenchymal 
stem cells (Gelse et. al., 2003). Cook and colleagues reported an articular cartilage defect 
repair by using BMP-7 in a canine model (Cook et. al., 2003). Madry and Cucchiarini 
summarized the clinical potential and the challenges of using genetically modified cells 
for articular cartilage repair. All these studies reflect persevering attempts for the repair 
of articular cartilage. However, there are still no significant studies on using genetically 
modified cells/gene therapy for auricular cartilage repair. 
In the study reported here, we have aimed to use this promising approach in an auricular 
cartilage defect. The defects were critical sized which means they cannot heal 
spontaneously. We used primary chondrocytes; genetically modified with BMP-7 
encoding plasmids, and furthermore applied them together with cryogel scaffolds for 
healing of cartilage defect in rabbit’s auricula. We have also followed early phase gene 
expressions. We try to describe the effects of BMP-7 expressed from genetically 
modified chondrocytes and whether it could support healing. We here hypothesized that 
using a tissue engineering approach with genetically modified BMP-7 expressing cells 
could be utilized in auricular cartilage defects that may exhibit improved cartilage tissue 
formation in a defined time. 
2. Materials and Methods 
2.1 Preparation of cryogel scaffolds  
All materials were obtained from Sigma-Aldrich (Germany) unless otherwise stated. 
Gelatin/ox-dextran scaffolds were prepared according to a previously reported procedure 
(Inci et al., 2011): Briefly; the cross-linker, oxidized dextran (oxDex), was synthesized by 
oxidation of dextran with sodium periodate in an aqueous media in the dark at room 
temperature for 1h (Maia et al., 2005). The oxidized dextran was separated by dialysis 
and freeze dried. For scaffold preparation, 2g gelatin was mixed with an appropriate 
amount of oxDex, and the mixture was transferred into 10 mm diameter tubes which were 
then frozen at -12°C in an ethanol-cooled cryostat for 1h. The disks were then stored in a 
freezer at -18°C for 24hrs. The frozen samples were taken from the tube, thawed at room 
temperature and washed with distilled water.  
Pore morphologies of the cryogels were examined using a scanning electron microscope 
(JSM-5600LV, Jeol, Japan) at 8 kV.  Compression tests were performed on wet scaffolds 
using a universal test machine (LR-5K, Lloyd Instruments, UK). Freeze-dried cryogels 
(Mo: dry weight) were allowed to swell until equilibrium (24 hrs) and were then 
weighted (Me: swollen weight). The swelling ratio (Sr) was calculated using the 
following equation. 
 Sr = [(Me - Mo)/ Mo] x 100                                                                              (1) 
2.2 Auricular Chondrocytes Isolation 
All procedures were approved by Gazi University Animal Ethic Committee (No: 
G.Ü.ET-10.059). Auricular cartilage was obtained from a 2 month old male New Zealand 
white rabbit under sterile conditions. Cartilage was cut into small pieces and digested in 
collagenase (3mg/ml in PBS) solution for 24 hours. The solution was then washed twice 
with DMEM/F12 culture medium. Isolated cells were then seeded into 25cm2 flasks and a 
condition medium (DMEM/F12, %10 FBS, %1 L-Glutamine, %0,25 Penicillin-
Streptomycin, %0,25 Gentamycin, % 0,1 Insulin). Chondrocytes were cultured until 
passage 4 at 5% CO2, 37oC. 
2.3 BMP-7 transfection and release studies  
The hBMP-7 cDNA containing constitutive expression plasmid pVAX1-hBMP7s 
(Feichtinger et al. 2011 in submission) was provided by the Ludwig Boltzman Institute, 
Vienna, Austria. Plasmid transfection was performed using a Turbofect in-vitro 
transfection kit (Fermentas, USA) according to manufacturer’s instructions. Briefly, 2 µl 
transfection agents were incubated with 5µg plasmids for about 15 minutes at room 
temperature. The solution was then added to the culture media/24 well plates. A day later, 
cells were trypsinized and seeded onto gelatin/ox-dextran scaffolds (1x105 cells/scaffold). 
BMP7 release into the culture media was analyzed for up to 14 days using BMP-7 Elisa 
Kits (RayBiotech , USA). Non-transfected cells were used as a control. In addition, 
transfection efficiencies of primary chondrocytes were performed using Green 
Florescence Protein encoding plasmid and transfection efficiencies were calculated. A 
student t-test was used to determine the effect of hBMP-7 to overall BMP-7 release in 
normal and transfected group. 
2.4 Cartilage tissue regeneration in vivo 
48 New Zealand (NZ)  white rabbits (adult male, 12 weeks olds, 2300 ± 300 gr with open 
epiphysis, healthy skeletal and physiological condition) which are equivalent to 96 
auricle samples were used in the following four main groups:  (i) The “defect-only” 
group which was the “control” group called as “Group C”;  (ii) the “scaffold only” group 
(“Group S”); (iii) scaffold seeded with primary chondrocytes (“Group N”); and (iv) 
scaffold seeded with genetically modified (transfected) primary chondrocytes group 
(“Group T”). In each group, 6 auricles were operated per month. 
In a typical surgical procedure, the rabbit was generally anesthetized intramuscularly 
using Ketamine (3ml) and Alfasime (1ml). In order to create a critical size defect 
15mmx15mm auricular cartilage tissue was removed 15 mm distal to the radix of each 
auricle. Critical size dimensions were selected by considering similar models applied in 
the literature (Cheqielski et al., 2007; Haberal et al., 2008). As seen in Figure 1, a special 
cutting device was designed and used to remove the standard dimensional cartilage tissue 
sample. Perichondrium and vascular territory was protected in each case. Note that the 
disk shaped scaffolds (diameter:  15 mm and height: 2 mm) were sterilized with 70% 
Ethanol and dried) before implantation. After implantation, the defect was closed with 3.0 
Caprosyn sutures (Syneture, Ireland). 
In Group C, the defect was closed without any further operation. In Group S, the cryogel 
scaffolds were implanted in the defect area. In Group N, the scaffold were first placed in 
the defect area and primary chondrocytes isolated from rabbit auricular cartilage tissues 
were then injected into the scaffold (1x106 cells per scaffold). In the last group (Group T), 
genetically modified primary cells (carrying the BMP-7 expressing plasmid) (1x106 cells 
per scaffold) were used. Cartilage reconstruction was monitored for up to 4 months. At 
the end of each month, operated cartilage tissue was removed from the defect area 
including the surrounding tissue. 
2.4.1 Early phase gene expression in vivo 
In order to investigate the effects of genetic modification, early gene expression of 
selected genes was performed in another set of animal studies. Here, 12 NZ White rabbits 
(adult male, 12 weeks olds) were used. 3 animals/auricles were used in each time-point 
for each treatment group. Others were kept as a control. Gene expression analysis was 
performed on normal and genetically modified cells groups. Non-operated tissue was 
used as a control. All animals were operated as described previously. Samples were 
collected from the implant sites on days 3, 7, 14 and 30 and all samples were immediately 
put into liquid nitrogen and kept at -80 until processed. 
Total RNA was isolated from the samples (approximately 50-100 mg) using the 
TriReagent system (peqGOLD TriFastTM, Peqlab, Erlangen, Germany), according to 
manufacturer’s instructions. The RNA-containing pellets were treated with approximately 
1–5U RNase-free D Nase (DNaseI, Roche Diagnostics, Germany) per µg RNA and 
incubated at 37°C for 30minutes before being washed with 70% ethanol to prevent DNA 
contamination. Ethanol was removed by air-drying and RNA pellets were dissolved in 
10-30µl of RNase and DNase free water after which it was air-dried. Isolated RNA was 
then stored at -80°C. The yield and quantity of the RNA of each sample was quantified 
by measuring absorbances at 260nm and 280nm using a Nanodrop spectrophotometer 
(NanoDrop ND-1000, USA). Equal amounts of RNA were used for reverse 
transcriptions. First strand complementary DNA (cDNA) was reverse transcribed from 
1µg of total RNA with the Transcriptor First Strand cDNA synthesis kit (Roche 
Diagnostics, Germany) according to the manufacturer’s instructions. cDNA products 
were stored at -20°C. 
For the expressions, Aggrecan, BMP-7, Collagen Type I (Col I) and Collagen Type II 
(Col II) mRNA levels were measured using qRT-PCR method with the LightCycler 480 
instrument (Roche Diagnostics, GmbH, Mannheim, Germany). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a housekeeping gene in order to 
normalize Aggrecan, BMP-7, Col Type I and Col Type II mRNA expression levels. 
Probes and exon-exon spanning primers for each gene assay were designed using the 
Universal Probe Library (UPL) Assay Design Center (Roche Applied Science, GmbH, 
Mannheim, Germany). The gene-specific primer sequences (exon-exon junction to allow 
discrimination between cDNA and genomic DNA) and UPL numbers are provided in 
Table 1.  
The reaction mixture was prepared in a 96 well plate using LightCycler Taq-Man Master 
Mix solution (Roche Diagnostics GmbH, Mannheim, Germany). Negative control 
experiments of each reaction were performed without the addition of template cDNA. 
Samples were analyzed in triplicate. In order to determine amplification efficiencies of 
the target genes, standard curves were constructed from samples used in a series of 
dilutions for both the gene of interest (GOI) and the housekeeping gene (GAPDH). GOI 
(Aggrecan, BMP-7, Col Type I and Col Type II) and GAPDH amplification efficiencies 
were approximately equal. The data were analyzed using LightCycler Software version 
3.5 (Roche Diagnostics GmbH, Mannheim, Germany). Gene expression analysis of 
Aggrecan, BMP-7, Col Type I and Col Type II was performed using the Relative 
Expression Software Tool 2005 (REST©) (Pfaffl et al., 2002).  
2.4.2 Histological evaluations 
Histological evaluation was performed at Hacettepe University, Faculty of Medicine, 
Department of Histology and Embryology. The observers were two experienced 
histologists (among the authors) and the samples were evaluated blindly.  The auricular 
specimens were removed and immersed in 10% neutral formalin solution (pH 7.0) at 
room temperature. Specimens were decalcified in De Castro solution (chloral hydrate, 
nitric acid, distilled water, Merck, Germany) and all samples were then  embedded in 
paraffin by using an automated tissue processor (Leica Westlar, Germany) with vacuum. 
Five to six micrometer thick serial sections (along the entire defect) were stained with 
hematoxylin & eosin (HE), Masson’s trichrome (MT) and Weigerts elastic stain to assess 
the general morphology, collagen and elastic fibril amount respectively. 
“Photomicrographs of each sample were generated by a light microscope (Leica, DMR, 
Germany) attached to a computerized digital camera (Model DFC 480, Leica Westlar 
Germany).  Both the Pinedas (the system has been modified by assessing the presence of 
the elastic cartilage but not the hyaline cartilage) and the Lohans cartilage histopathology 
scoring systems were used to evaluate the auricular cartilage critical sized defect healing. 
(Lohan et al., 2011; Pineda et al., 1992). 
Statistical analysis 
A prospective randomized-controlled double-blinded in vivo study was designed. 
Independent variables were groups (n=8 ) and time (n=2)  Dependent variables were 
histology scores. For statistical analysis, the independent variable was groups and the 
dependent variables were the histology. The normality of distribution and the 
homogeneity of variances of the sample were established using the Shapiro-Wilk test. All 
parameters were analyzed by the non-parametric Kruskal-Wallis test that was used for 
multiple comparisons and the Dunn test for post-hoc analysis. Descriptive statistics were 
expressed as the median, the minimum and the maximum. Statistical significance was 
determined using the SPSS software (version 15.0). The differences were considered 
significant when p < 0.05. 
For the gene expression results, statistical significance of differences in mRNA 
expression were analyzed by a pairwise fixed reallocation randomization test as a 
statistical model included in the relative expression software tool (REST©, Qiagen, USA) 
developed for group-wise comparison and statistical analysis of relative expression 
results. The differences were considered significant when p < 0.05. 
3. RESULTS and DISCUSSION 
3.1 Cryogel scaffolds 
Figure 2 shows a representative SEM micrograph of the cryogel scaffolds prepared in this 
study. As seen here, cryogels are highly porous, with large pores (the average is over 100 
µm) and inter-connective pore morphology, which are very suitable structural properties 
for porous materials in tissue engineering (Nickerson et al., 2006; Jain et al., 2008). 
One of the important properties of these cryogel scaffolds is their swelling ability and 
behavior. They do swell in aqueous media very rapidly, within a few minutes, and reach 
their final size in 20-25 mins. The average swelling ratio and standard deviation (n:5) is 
986.2% ± 134.0 which is in the range of the data reported in the related literature for 
similar dextran based cryogels (Nickerson et al., 2006; Jain et al., 2008)  
The average elastic moduli and toughness and with the corresponding standard deviations 
(n:5) obtained from the compression tests are 8.4 kPa ± 1.8 and 261.0 ± 67.5 kJ/m3, 
respectively, which are comparable to the mechanical properties of similar 
cryogels/hydrogels reported in the literature (Inci et al., 2012; Nickerson et al., 2006;  Al-
Munajjed et al., 2009). 
3.2 BMP release studies 
 
Figure 3 depicts the BMP-7 release from cryogels loaded with genetically modified 
chondrocytes (transfected - carrying BMP-7 expressing plasmids) and scaffolds seeded 
with non-transfected chondrocytes obtained in the in-vitro cell culture media as described 
in the previous sections. It has been reported that cells on monolayer cultures do lose 
their ability to encode the specific genes for ECM proteins and change their morphology 
from chondrocytic to fibroblastic (Hiraki et al. 1985; Stokes et al. 2001) As seen in 
Figure 3, the non-transfected cells also synthesize BMP-7, however to a much lower 
extent and decreasing with time. As, was our aim in this study, transfected cells 
expressed/released BMP-7 in much higher amounts and for longer periods. There is a 
significant difference between normal and transfected cells in all timepoints. (p < 0.01 to 
p < 0.0001) Schüller and his colleagues demonstrated similar relevant findings with 
BMP-7 release from primary chondrocytes, transfected with pCMV-BMP7/lipofectamine 
system in monolayer culture (Schüller et al., 2008).  
Here we analyze the total BMP7 (both endogenous and in transfected cells also 
exogenous) release to the culture media. BMP release in this study is also related to 
transfection efficiency. In our study, we checked our transfection efficiencies in primary 
chondrocytes, which were between 15-20%, with a model plasmid (EGFP). Logically, 
higher transfection efficiency causes higher amounts of produced BMP.  There are 
several issues that strongly affect the transfection efficiency. In brief; primary cells are 
very sensitive to the transfection and isolation procedures from the tissue can also affect 
the efficiency (Dinser et al., 2001)  Also although the transfections with non-viral vectors 
are much safer in primary cell culture, transfection efficiencies with non-viral vectors are 
lower than with viral vectors (Al-Dosari et al., 2009)  
3.3 Cartilage tissue regeneration in vivo 
A detailed histological evaluation was performed in all groups. Figure 4 and Figure 5 
show the average Pineda and Lohan scores of each group within 4 months. 
These scoring systems are widely used and well established scoring systems for cartilage 
repair assessment used in the recent literature and studies. Although they are described as 
semi-quantitative systems, they cover and combine all of the morphologic criteria for 
qualitative and quantitative cartilage repair. In Lohan’s scoring system the cartilage cell 
morphology, extracellular matrix production and the inflammation criteria were 
separately scored. In Pineda’s scoring system the filling percentage of the defect, the 
reconstruction of osteochondral junction, extracellular matrix staining by Weigert elastic 
stain (which reveal the presence of elastic fibers), the amount of chondrocyte and non-
chondrocyte cells and the amount of the fibrous and elastic cartilage were separately 
scored. The final total scores that included all this data were statistically analyzed. 
In addition to these semi-quantitative scoring of newly formed elastic cartilage; all groups 
were also analyzed by histological staining.  Figure 6 shows histological staining for all 
groups. 
According to histological assessment, all of the defects were closed by the formation of 
fibrous connective tissue and cartilage (fibrous and elastic) at the end of 4 months. Repair 
in the control group was mainly by way of connective tissue formation. The biomaterial 
degraded in time but did not degrade entirely at the end of 4 months in any of the groups. 
All of the groups exhibited the formation of various amounts of cartilage islands and 
several of them revealed a varying quantity of calcified foci within the defect. Both cell 
seeded scaffold groups had more Weigert positive elastic cartilage islands compared to 
the other groups. Cartilage formation was of a more fibrous type in the control and 
scaffold only groups (Group C and Group S). Although the scaffold was biocompatible, 
allowing good guidance for cartilage regeneration, it was not enough to support elastic 
cartilage formation over a period of 4 months in the entire defect in-vivo. The new 
cartilage-like tissue was not completely homogeneous and it was sometimes continuous 
with the fibrous connective tissue throughout the defect in all of the groups (Figure 6).  
The normal and the genetically modified (transfected) cells with scaffold groups (Group 
N and Group T)  received significantly better Pineda and Lohan defect healing scores 
than those of the control (Group C) and the scaffold only group (Group S)  at one month 
(Group N p=0.023 and p=0.001 ; Groups T p=0.001 and p=0.001) . The transfected and 
normal cells with scaffold groups (Group N and Group T) were significantly better than 
the scaffold only group (Group S) after one month (Figure 4 and 5) (Group N p=0.03 
Lohan ; Group T p=0.001 and p=0.001). 
The transfected cells with scaffold group (Group T) received significantly better Pineda 
and Lohan defect healing scores than those of the control at 2 months (Group T; p=0.001 
and p=0.001). The transfected cells with scaffold group was better than the scaffold only 
group (Group S) according to Lohan scoring at 2 months (p=0.001) (Figure 4). At 3 
months; the transfected cells with scaffold group (Group T)   was better than the control 
according to Lohan (p=0.003) and; the normal cells with scaffold group (Group N) was 
better than the control according to Pineda (p=0.007) (Figure 4 and 5). At 4 months; the 
transfected cells with scaffold group (Group T) was better than the control according to 
Pineda and Lohan (p=0.001 and p=0.002). The transfected cells with scaffold group 
(Group T) was significantly better than the scaffold only group (Group S) (p=0.012) 
according to Lohan after month 4 (Figure 4 and 5). 
The scaffold only group (Group S)  did not significantly improve the cartilage defect 
healing process in the months 1, 2, 3 and 4 compared to control (Group C)  (Figure 4 and 
5). 
3.4 Early phase gene expressions 
 
In order to observe  the effects of BMP-7 on early phase healing process, a separate group 
of experiments was designed, in which scaffolds carrying primary chondrocytes (normal 
cells) or their genetically modified forms (transfected) were implanted to the animal ear 
models (3 animals for each) as discussed in the previous section. The samples were taken 
at 3rd, 7th, 14th and 30th days and expression of four target genes, i.e., COL Type I and II, 
BMP-7 and Aggrecan was analyzed by quantitative Real-Time PCR.  
The selected factors/genes are related to cartilage tissue formation and ECM synthesis. 
Briefly as follows: BMP-7 which stimulates the chondrogenesis and matrix synthesis; 
COL Type II, which is the dominant ECM protein in auricular cartilage; Aggrecan, which 
is a cartilage specific proteoglycan core protein; and finally COL Type I, which naturally 
exist in bone and fibrous cartilage. 
Figure 7 shows the fold differences in expression with respect to the control in designated 
timepoints. As is seen in figure 7, there was an increase in synthesis of all selected factors 
over time. BMP-7 plays a role in enhancing matrix synthesis in cartilage tissue formation. 
Therefore, if there is an activity of BMP-7, matrix protein synthesis should consequently 
increase (Bessa et al., 2008). In this study the expression of endogenous BMP7 was on 
mRNA level, however, several reports show that exogenous BMPs (that come from the 
plasmid) can elevate the levels of endogenous BMPs and have an induced effect on the 
synthesis of mRNAs as well as matrix synthesis and tissue development (Erickson et al., 
1997 ; Chen et al.,  1997 ; Kawai  et al., 2006).   In addition; Aggrecan, which is a 
specific matrix protein for cartilage, and Collagen type II, which is the dominant matrix 
protein for cartilage, were also increased, both in transfected and normal cells with 
scaffold groups (Group N and Group T). However, in transfected cells with scaffold 
group (Group T) these differences were significant and higher in all timepoints. The 
effect of the extra BMP-7 can be observed easily after 14 days post-operative as the 
matrix proteins synthesis increases. Even in the late phase (14 and 30 days), there is still a 
higher expression of Collagen Type II and Aggrecan in Group T. Lietman and colleagues 
reported similar findings on the stimulation of proteoglycan synthesis by Bone 
Morphogenetic Protein – 7 (Lietman  et al., 1997).  On the other hand, Collagen Type I 
differences in normal cells with scaffold group (Group N) is not significant at later phases 
(after 14 days) in normalized overall results. However, in Group T, a higher expression 
on Collagen Type I was observed at later phases (14 days). This observation can be 
explained by the role of BMP-7 in bone and cartilage regeneration (Bessa et al., 2008). 
BMP-7 activates cartilage matrix synthesis and has a role in chondrogenesis, however, it 
also activates bone formation and dominates the synthesis of bone related matrix proteins. 
Therefore, existence of extra BMP-7 in the microenvironment in transfected cells with 
scaffold group (Group T) could have also increased the level of Collagen Type I 
significantly. Briefly; the fold differences of the selected factors in group T were higher 
than normal cells (untransfected) cells with scaffold group (Group N) for every timepoint.  
Cartilage tissue has a limited regenerative capacity due to its avascular structure. In order 
to regenerate the tissue, essential growth factors should be present in the 
microenvironment. The use of genetically engineered cells to enhance cartilage healing 
and tissue forming is the main target of the present study. In our study, we used a 
syngenic animal model belonging to an inbred strain. The animals were sufficiently 
identical and immunologically compatible. In addition, inflammation is a critical point 
during tissue regeneration. In our study both treatments groups and the control group 
presented similar inflammation scores revealing no obvious immunologic response 
(supplementary Table 1). Despite these facts, using a syngenic model may still refer as a 
limitation of our study when considering to translate into clinic.  
As our histology and gene expression results indicated a significantly better cartilage 
healing and matrix formation in genetically modified cells individually with exogenous 
BMP-7. However, we could not correlate the results of histology and early gene 
expression together due to the different variable numbers and incompatible time points 
which might be stated as an other limitation. Moreover, the expression and the release of 
the plasmid encoded factors mainly depend on the transfection and expression efficiency, 
which is relatively low in primary cells with non-viral systems. We believe, higher 
expression efficiency could have an additional effect on healing. Although the 
histological staining and the results of the semi-quantitative scoring system exhibit a 
well-organized almost elastic tissue formation on transfected cells applied group (Group 
T), we believe that further studies are needed to elucidate the exact mechanism of the 
elastic formation and long term regeneration. 
CONCLUSION 
There is still a need for novel therapies for the reconstruction of auricular cartilage. 
Although there are some surgical approaches including autologous cartilage grafts or 
prostheses, they all have some disadvantages and risks. Therefore, auricular 
reconstruction still remains one the most difficult field of  reconstruction surgery for head 
and neck surgery.   
In this study, we aimed to perform a cartilage defect healing model on auricular side, 
which would allow the regeneration of cartilage tissue as well as forming a cartilage 
tissue, very similar to native auricular cartilage. We envisage the possible treatment of 
cartilage defects via tissue engineering approaches. 
Our results demonstrate that proper cartilage tissue was formed at the end of 4 months 
using genetically modified primary chondrocytes that over expressed human BMP7. 
Significantly improved healing and regeneration was observed which was attributed to 
the effect of over-expressed BMP7.  
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Table 1. The gene-specific primer and probe sequences. 
Gene Forward Primer Reverse Primer UPL 
prob
e no. 
UPL Probe 
 5`-FAM-
sequence 
-TAMRA- 3` 
GAPDH 5′-CACAGTTTCCATCCCAGACC-3′ 5′-TGGTTTCATGACAAGGTAGGG-3′ 25 TGGAGGAG 
Aggrecan 5′-CAGGAGGCAGCCAGTGAG-3′ 5′-GGTAGAGCTGGCCTGTGGT-3′ 28 GCGGCTGG 
BMP-7 5’-CCTGTTAACCAGCCAAGTCG-3’ 5’-CGCTCGGTTACCTCTGGA-3’ 71 CTGGCTGC 
Col Type I 5′-AGAACCCAGCTCGCACCT-3′ 5′-CATCCTTGGTTGGGATCG-3′, 83 CAGCCACC 
Col Type II 5′-GACCTGCGTCTACCCCAAC-3′ 5′-GCTGCTTCTGGCTCTTGC-3′ 22 TGGTGGAG 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Rabbit ear critical size defect model. (A) Removal of auricular cartilage with a 
special cutting device; (B) intact auricular cartilage removed from the defect area; (C) 
cryogel scaffolds implanted in the defect area;  (D) Replacing the perichondrium in the 
original site/position; (E) imaging of the transplanted site by light illumination; (F) 
injection of cells into the implanted scaffold. 
 
Figure 2. SEM micrograph of the cryogel scaffold used in this study. 
 Figure 3.  BMP-7 release (both endogenous and exogenous) from cryogels scaffold 
carrying either genetically modified (transfected) primary chondrocytes or non-
transfected chondrocytes. Production per day. (N=3)  
*; p<0.05 when comparison with normal and transfected cells. 
 
 
Figure 4.   Lohan Histologic Scoring of each groups (N:6) (C: Control; S:Scaffolds; N: 
Scaffolds with chondrocytes; and T:Scaffolds with transfected cells)  *; p<0.05 
 
 
Figure 5.   Pineda Histologic Scoring of each groups (N:6) (C: Control; S:Scaffolds; N: 
Scaffolds with chondrocytes; and T:Scaffolds with transfected cells) *; p<0.05 
 Figure 6.  These are the panoramic views of the cartilage defects at lowest (25x) 
magnification. Elastic fibers stain in black with this dye. Bone, fibrous cartilage and the 
connective tissue  stain in purple to yellow. The pink to purple color of the extracellular 
matrix exhibit an intermediate stage of the repairing or remodeling cartilage before the 
accumulation of the elastic fibers (in J, M, P).The asterisks show the edge between the 
defect and the adjacent  elastic cartilage which is normal or under the remodeling process. 
In J and O new elastıc cartılage; ın H, L and P bone formation is observed inside the 
defect. EC: Elastic cartilage, FC: Fibrous cartilage, FCT: Fibrous connective tissue, B: 
Bone. Note that the elastic cartilage development is at the highest level in cells with 
scaffold applied groups at the bottom lines. Weigert elastic stain. Scales in each figure 
represent 1mm.    
 
 Figure 7.  The fold differences in mRNA level of BMP-7, Col Type I, Col Type II, 
Aggrecan in cell applied groups with respect to the control up to 30 days. Non-operated 
tissue was used as a control. Results were normalized to GAPDH as housekeeping gene. 
*; p<0.05 when comparison with control and cell applied groups 
**; p<0.05 when comparison between Normal and Transfected Cells applied groups. 
 
 
 
